Boston Scientific (NYSE:BSX) traded today at a new 52-week high of $7.60. Approximately 5.9 million shares have changed hands today, as compared to an average 30-day volume of 19.3 million shares.

Boston Scientific share prices have moved between a 52-week high of $7.60 and a 52-week low of $4.79 and are now trading 58% above that low price at $7.57 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 2.8%.

Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.

Boston Scientific (NYSE:BSX) defies analysts with a current price ($7.57) 9.0% above its average consensus price target of $6.89. The stock should discover initial support at its 50-day moving average (MA) of $6.02 and subsequent support at its 200-day MA of $5.72.

SmarTrend recommended that subscribers consider buying shares of Boston Scientific on November 26th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $5.73. Since that recommendation, shares of Boston Scientific have risen 30.5%. We continue to monitor BSX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.